ask="14.40"
ask_size="200"
average_daily_volume="165269"
bid="11.10"
bid_size="200"
book_value="3.69"
change="-0.40"
change_from_200_day_moving_average="1.39"
change_from_50_day_moving_average="-0.58"
change_from_52_week_high="-2.90"
change_From_52_week_low="7.82"
change_in_percent="-3.31%"
close="11.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.17"
ebitda="-38.95M"
eps_estimate_current_year="-2.14"
eps_estimate_next_quarter="-0.53"
eps_estimate_next_year="-1.98"
ex_dividend_date="N/A"
float_shares="15638000"
high="12.25"
high_52_weeks="14.60"
last_trade_date="1/18/2017"
last_trade_price="11.70"
last_trade_size="3662"
last_trade_time="4:00pm"
low="11.55"
low_52_weeks="3.88"
market_capitalization="208.80M"
moving_average_200_day="10.31"
moving_average_50_day="12.28"
name="Stemline Therapeutics
Inc."
notes="N/A"
one_year_target_price="29.25"
open="12.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+13.49%"
percent_change_from_50_day_moving_average="-4.69%"
percent_change_from_52_week_high="-19.86%"
percent_change_from_52_week_low="+201.55%"
previous_close="12.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.28"
price_per_sales="227.88"
revenue="947604.00"
shares_outstanding="17846000"
short_ratio="7.54"
stock_exchange="NCM"
symbol="STML"
volume="149700"
weeks_range_52="3.88 - 14.60"
